Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 known ✓ | P03956 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668625 | 0.98 | MMP1 (0.32) | SPHK1MMP1MMP2MMP3MMP9 | |
| Ammonia Solution, Strong SCHEMBL28256364 | 0.95 | MMP1 (0.31) | MMP1MMP2MMP3MMP9EPHX1 | |
| Buformin SCHEMBL3644254 | 0.87 | GRIN2D (0.42) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL15669256 | 0.87 | GRIN2D (0.42) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL6018 | 0.87 | GRIN2D (0.42) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL749659 | 0.87 | GRIN2D (0.42) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL3455307 | 0.85 | GRIN2D (0.41) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL1048416 | 0.85 | GRIN2D (0.41) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL22436277 | 0.85 | GRIN2D (0.41) | SPHK1MMP2EPHX1NOS3NOS1 | |
| Buformin SCHEMBL4656049 | 0.85 | GRIN2D (0.41) | SPHK1MMP2EPHX1NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160296449-A1 | Semi-Permanent Hair Straightening Composition And Method | LUBRIZOL ADVANCED MATERIALS, INC. | 2016-10-13 | — | — | US | claimed |
| EP-3065831-A1 | SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD | Lubrizol Advanced Materials, Inc. (US) | 2016-09-14 | — | — | EP | claimed |
| EP-2826461-B1 | Method for straightening keratin fibres using a heating means and a denaturing agent | ORÉAL L (FR) | 2016-06-01 | — | — | EP | claimed |
| WO-2015069823-A1 | SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2015-05-14 | — | — | WO | claimed |
| US-20100284954-A1 | PROCESS FOR RELAXING KERATIN FIBRES | L'OREAL (FR) | 2010-11-11 | — | — | US | claimed |
| US-20060127337-A1 | Process for relaxing keratin fibres | L'OREAL (FR) | 2006-06-15 | — | — | US | claimed |
| US-11572341-B2 | Biguanide compound and use thereof | IMMUNOMET THERAPEUTICS INC. (US) | 2023-02-07 | — | — | US | disclosed |
| WO-2022181457-A1 | WIPE SHEET AND AQUEOUS COMPOSITION FOR IMPREGNATING WIPE SHEET | レック株式会社 | 2022-09-01 | — | — | WO | disclosed |
| US-11399611-B2 | Process for straightening keratin fibres with a heating means and denaturing agents | L'OREAL (FR) | 2022-08-02 | — | — | US | disclosed |
| US-10449134-B2 | Process for treating keratin fibres with a composition comprising an amino acid | L'OREAL (FR) | 2019-10-22 | — | — | US | disclosed |
| US-20190125051-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | L'OREAL (FR) | 2019-05-02 | — | — | US | disclosed |
| US-20180042831-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A COMPOSITION COMPRISING AN AMINO ACID | L'OREAL (FR) | 2018-02-15 | — | — | US | disclosed |
| EP-3259030-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A COMPOSITION COMPRISING AN AMINO ACID | L'OREAL (FR) | 2017-12-27 | — | — | EP | disclosed |
| US-20100028280-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | L'OREAL S.A. (FR) | 2010-02-04 | — | — | US | disclosed |
| WO-2008109598-A2 | LENS CARE SOLUTIONS FOR USE WITH CONTACT LENSES OR CONTACT LENS CASES THAT CONTAIN SILVER | BAUSCH & LOMB INCORPORATED (US) | 2008-09-12 | — | — | WO | disclosed |
| US-20080218686-A1 | LENS CARE SOLUTIONS FOR USE WITH CONTACT LENSES OR CONTACT LENS CASES THAT CONTAIN SILVER | BAUSCH & LOMB INCORPORATED | 2008-09-11 | — | — | US | disclosed |
| US-20080214421-A1 | CONTACT LENS CARE COMPOSITION | BAUSCH & LOMB INCORPORATED | 2008-09-04 | — | — | US | disclosed |
| WO-2007146683-A2 | OPHTHALMIC COMPOSITIONS COMPRISING A BRANCHED, GLYCEROL MONOALKYL COMPOUND AND A FATTY ACID MONOESTER | BAUSCH & LOMB INCORPORATED (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070286767-A1 | Ophthalmic Compositions Comprising a Branched, Glycerol Monoalkyl Compound and a Fatty Acid Monoester | BAUSCH & LOMB PHARMA HOLDINGS CORP. | 2007-12-13 | — | — | US | disclosed |
| US-20060127337-A1 | Process for relaxing keratin fibres | L'OREAL (FR) | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11399611-B2 | Process for straightening keratin fibres with a heating means and denaturing agents | KRT18, KRTCAP2, TUBB4A | MMP1 686/4885SPHK1 1845/4885MMP2 488/4885 |
| US-20100028280-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | KRT18, KRTCAP2, TUBB4A | MMP1 686/4885SPHK1 1845/4885MMP2 488/4885 |
| US-20100284954-A1 | PROCESS FOR RELAXING KERATIN FIBRES | KRT18, TPM4, MYLK | MMP1 371/4885SPHK1 3460/4885MMP2 498/4885 |
| US-11572341-B2 | Biguanide compound and use thereof | MKI67, GCG, GCKR | MMP1 1508/4885SPHK1 1169/4885MMP2 463/4885 |
| US-20160296449-A1 | Semi-Permanent Hair Straightening Composition And Method | KRT18, PRKDC, DNMT1 | MMP1 520/4885SPHK1 1834/4885MMP2 469/4885 |
| US-20190125051-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | KRT18, KRTCAP2, TUBB4A | MMP1 686/4885SPHK1 1845/4885MMP2 488/4885 |
| US-20060127337-A1 | Process for relaxing keratin fibres | KRT18, TPM4, MYLK | MMP1 371/4885SPHK1 3460/4885MMP2 498/4885 |
| US-10449134-B2 | Process for treating keratin fibres with a composition comprising an amino acid | KRT18, OAT, MYOC | MMP1 913/4885SPHK1 2206/4885MMP2 2089/4885 |
| US-20180042831-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A COMPOSITION COMPRISING AN AMINO ACID | KRT18, OAT, MYOC | MMP1 1163/4885SPHK1 2608/4885MMP2 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.